What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Disease
His primary scientific interests are in Psychiatry, Depression, Internal medicine, Clinical psychology and Anxiety.
Number needed to treat is closely connected to Randomized controlled trial in his research, which is encompassed under the umbrella topic of Psychiatry.
His work investigates the relationship between Depression and topics such as Alzheimer's disease that intersect with problems in Degenerative disease.
His study in Internal medicine is interdisciplinary in nature, drawing from both Placebo, Endocrinology and Mood.
His study focuses on the intersection of Clinical psychology and fields such as Sleep disorder with connections in the field of Slow-wave sleep, Physical therapy and Audiology.
His biological study spans a wide range of topics, including Grief, Traumatic grief and Complicated grief.
His most cited work include:
- The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. (15382 citations)
- Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale (1435 citations)
- Inventory of Complicated Grief: A scale to measure maladaptive symptoms of loss (985 citations)
What are the main themes of his work throughout his whole career to date?
Charles F. Reynolds spends much of his time researching Psychiatry, Depression, Clinical psychology, Internal medicine and Late life depression.
He focuses mostly in the field of Psychiatry, narrowing it down to topics relating to Dementia and, in certain cases, Alzheimer's disease.
His research integrates issues of Pharmacotherapy, Randomized controlled trial and Cognition in his study of Depression.
His Randomized controlled trial research includes themes of Psychological intervention, Physical therapy and Clinical trial.
The Clinical psychology study combines topics in areas such as Grief, Complicated grief and Sleep disorder.
His Internal medicine research incorporates elements of Venlafaxine, Placebo, Endocrinology and Cardiology.
He most often published in these fields:
- Psychiatry (48.70%)
- Depression (43.79%)
- Clinical psychology (19.24%)
What were the highlights of his more recent work (between 2014-2021)?
- Depression (43.79%)
- Psychiatry (48.70%)
- Clinical psychology (19.24%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Depression, Psychiatry, Clinical psychology, Late life depression and Internal medicine.
His research in Depression intersects with topics in Intervention, Randomized controlled trial and Anxiety.
Charles F. Reynolds regularly ties together related areas like Physical therapy in his Randomized controlled trial studies.
The study incorporates disciplines such as Clinical trial and Dementia in addition to Psychiatry.
He has included themes like Psychotherapist, Grief, Complicated grief, Rating scale and Cognition in his Clinical psychology study.
His work in Internal medicine covers topics such as Placebo which are related to areas like Aripiprazole.
Between 2014 and 2021, his most popular works were:
- Sleep and mental disorders: A meta-analysis of polysomnographic research. (249 citations)
- Management of Depression in Older Adults: A Review. (196 citations)
- Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial. (121 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Major depressive disorder
Charles F. Reynolds focuses on Depression, Psychiatry, Clinical psychology, Internal medicine and Late life depression.
His Depression study integrates concerns from other disciplines, such as Mood, Clinical trial, Comorbidity and Rating scale.
His Psychiatry study typically links adjacent topics like Dementia.
His research in Clinical psychology tackles topics such as Psychological intervention which are related to areas like Intervention.
His Internal medicine research is multidisciplinary, incorporating elements of Major depressive disorder, Placebo and Oncology.
He has researched Late life depression in several fields, including Hyperintensity, Cardiology, Pathology, Neuroimaging and Antidepressant.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
